Evaluation of biventricular function in patients with COVID-19 using speckle tracking echocardiography
A new infectious outbreak sustained by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is now spreading all around the world. The aim of this study was to evaluate the prognostic value of left ventricular global longitudinal strain (LV-GLS) and right ventricular longitudinal strain (RV-LS) in patients with coronavirus disease 2019 (COVID-19). In this prospective, single-center study, data were gathered from patients treated for COVID-19 between April 15 and April 30, 2020. Two-dimensional echocardiography (2-DE) and speckle tracking echocardiography (STE) images were obtained for all patients. Patients were divided into three groups: those with severe COVID-19 infection, those with non-severe COVID-19 infection, and those without COVID-19 infection (the control group). Data regarding clinical characteristics and laboratory findings were obtained from electronic medical records. The primary endpoint was in-hospital mortality. A total of 100 patients hospitalized for COVID-19 were included in this study. The mean age of the severe group (n = 44) was 59.1 ± 12.9, 40% of whom were male. The mean age of the non-severe group (n = 56) was 53.7 ± 15.1, 58% of whom were male. Of these patients, 22 died in the hospital. In patients in the severe group, LV-GLS and RV-LS were decreased compared to patients in the non-severe and control groups (LV-GLS: - 14.5 ± 1.8 vs. - 16.7 ± 1.3 vs. - 19.4 ± 1.6, respectively [p < 0.001]; RV-LS: - 17.2 ± 2.3 vs. - 20.5 ± 3.2 vs. - 27.3 ± 3.1, respectively [p < 0.001]). The presence of cardiac injury, D-dimer, arterial oxygen saturation (SaO2), LV-GLS (OR 1.63, 95% confidence interval [CI] 1.08-2.47; p = 0.010) and RV-LS (OR 1.55, 95% CI 1.07-2.25; p = 0.019) were identified as independent predictors of mortality via multivariate analysis. LV-GLS and RV-LS are independent predictors of in-hospital mortality in patients with COVID-19.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
---|---|
Enthalten in: |
The international journal of cardiovascular imaging - 37(2021), 1 vom: 17. Jan., Seite 135-144 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Baycan, Omer Faruk [VerfasserIn] |
---|
Links: |
---|
Themen: |
Biventricular function |
---|
Anmerkungen: |
Date Completed 22.02.2021 Date Revised 18.02.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s10554-020-01968-5 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM313780900 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM313780900 | ||
003 | DE-627 | ||
005 | 20231225151315.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s10554-020-01968-5 |2 doi | |
028 | 5 | 2 | |a pubmed24n1045.xml |
035 | |a (DE-627)NLM313780900 | ||
035 | |a (NLM)32803484 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Baycan, Omer Faruk |e verfasserin |4 aut | |
245 | 1 | 0 | |a Evaluation of biventricular function in patients with COVID-19 using speckle tracking echocardiography |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.02.2021 | ||
500 | |a Date Revised 18.02.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a A new infectious outbreak sustained by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is now spreading all around the world. The aim of this study was to evaluate the prognostic value of left ventricular global longitudinal strain (LV-GLS) and right ventricular longitudinal strain (RV-LS) in patients with coronavirus disease 2019 (COVID-19). In this prospective, single-center study, data were gathered from patients treated for COVID-19 between April 15 and April 30, 2020. Two-dimensional echocardiography (2-DE) and speckle tracking echocardiography (STE) images were obtained for all patients. Patients were divided into three groups: those with severe COVID-19 infection, those with non-severe COVID-19 infection, and those without COVID-19 infection (the control group). Data regarding clinical characteristics and laboratory findings were obtained from electronic medical records. The primary endpoint was in-hospital mortality. A total of 100 patients hospitalized for COVID-19 were included in this study. The mean age of the severe group (n = 44) was 59.1 ± 12.9, 40% of whom were male. The mean age of the non-severe group (n = 56) was 53.7 ± 15.1, 58% of whom were male. Of these patients, 22 died in the hospital. In patients in the severe group, LV-GLS and RV-LS were decreased compared to patients in the non-severe and control groups (LV-GLS: - 14.5 ± 1.8 vs. - 16.7 ± 1.3 vs. - 19.4 ± 1.6, respectively [p < 0.001]; RV-LS: - 17.2 ± 2.3 vs. - 20.5 ± 3.2 vs. - 27.3 ± 3.1, respectively [p < 0.001]). The presence of cardiac injury, D-dimer, arterial oxygen saturation (SaO2), LV-GLS (OR 1.63, 95% confidence interval [CI] 1.08-2.47; p = 0.010) and RV-LS (OR 1.55, 95% CI 1.07-2.25; p = 0.019) were identified as independent predictors of mortality via multivariate analysis. LV-GLS and RV-LS are independent predictors of in-hospital mortality in patients with COVID-19 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Biventricular function | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Speckle tracking echocardiography | |
700 | 1 | |a Barman, Hasan Ali |e verfasserin |4 aut | |
700 | 1 | |a Atici, Adem |e verfasserin |4 aut | |
700 | 1 | |a Tatlisu, Adem |e verfasserin |4 aut | |
700 | 1 | |a Bolen, Furkan |e verfasserin |4 aut | |
700 | 1 | |a Ergen, Pınar |e verfasserin |4 aut | |
700 | 1 | |a Icten, Sacit |e verfasserin |4 aut | |
700 | 1 | |a Gungor, Baris |e verfasserin |4 aut | |
700 | 1 | |a Caliskan, Mustafa |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The international journal of cardiovascular imaging |d 2001 |g 37(2021), 1 vom: 17. Jan., Seite 135-144 |w (DE-627)NLM113949219 |x 1875-8312 |7 nnns |
773 | 1 | 8 | |g volume:37 |g year:2021 |g number:1 |g day:17 |g month:01 |g pages:135-144 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10554-020-01968-5 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 37 |j 2021 |e 1 |b 17 |c 01 |h 135-144 |